FBInvestor
Stocks / Lineage Cell Therapeutics In
Institutional Ownership

Lineage Cell Therapeutics In

CUSIP 53566P109COMLCTXQ1 2026

No Form 4 insider transactions ingested yet

Insider (Form 4) filings for Lineage Cell Therapeutics In are fetched from SEC EDGAR on a rolling basis. Check back shortly.